A Single Center Open-label, Randomized, Single-dose, 3-way Crossover Study to Compare the Safety, Tolerability, and Pharmacokinetics of Lacosamide Administered as Oral Tablet or Intravenous Infusion in Healthy Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2014
Price : $35 *
At a glance
- Drugs Lacosamide (Primary) ; Lacosamide (Primary)
- Indications Fibromyalgia; Osteoarthritis; Partial epilepsies; Sleep disorders; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Pharma SA
- 03 Nov 2014 Last checked against ClinicalTrials.gov record.
- 08 Jan 2014 Status changed to completed as reported by ClinicalTrials.gov record.
- 24 Nov 2013 New trial record